- €10.37bn
- €14.09bn
- €8.91bn
- 39
- 69
- 74
- 68
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.33 | ||
| PEG Ratio (f) | 0.73 | ||
| EPS Growth (f) | 11.16% | ||
| Dividend Yield (f) | 7.13% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.34 | ||
| Price to Tang. Book | 1.69 | ||
| Price to Free Cashflow | 16.15 | ||
| Price to Sales | 1.16 | ||
| EV to EBITDA | 8.97 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.35% | ||
| Return on Equity | 14.74% | ||
| Operating Margin | 14.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 11,713 | 12,998 | 7,321 | 7,861 | 8,911 | 10,975.33 | 10,283.5 | -8.69% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +22.98 | -25.1 | +32.08 | -15.07 | +9.4 | +12.53 | +8.54 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ageas SA is a Belgium-based international insurance company. The Company's business segments include Belgium; Europe (excluding Belgium); Asia; Reinsurance; and General account. The Belgian insurance activities operate under the name of AG Insurance. The Company's business in the United Kingdom is a national provider of Nonlife insurance solutions. The Company's Europe segment consists of the insurance activities of the Company in Europe, excluding Belgium and the United Kingdom. The Company operates in a number of countries in Asia with its regional office and the fully owned subsidiary both based in Hong Kong. The Reinsurance segment operates through Intreas NV a subsidiary from the Company, which works as an internal reinsurance. The General Account comprises activities not related to the core Insurance business, such as group finance and other holding activities.
Directors
- Bart De Smet CHM (63)
- Hans De Cuyper CEO (51)
- Guy de Selliers de Moranville NVC (68)
- Christophe Boizard CFO (61)
- Emmanuel Van Grimbergen CRO (53)
- Antonio Cano MDR (57)
- Filip Coremans MDR (57)
- Veerle Verbessem DIR
- Steven Braekeveldt OTH (61)
- Gary Crist OTH (63)
- Heidi Delobelle OTH
- Andy Watson OTH (58)
- Valerie Van Zeveren SEC
- Sonali Chandmal NID (53)
- Richard Jackson NID (64)
- Yvonne Lang Ketterer NID (55)
- Jane Murphy NID (53)
- Lionel Perl NID (72)
- Lucrezia Reichlin NID (66)
- Katleen Vandeweyer NID (51)
- Jan Zegering Hadders NID (74)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 9th, 1993
- Public Since
- March 6th, 1990
- No. of Employees
- 17,677
- Sector
- Insurance
- Industry
- Financials
- Exchange
Euronext - Brussels- Shares in Issue
- 193,073,286
- Address
- Avenue du Boulevard 21, BRUXELLES, 1210
- Web
- https://www.ageas.com/
- Phone
- +32 25575711
- Contact
- Veerle Verbessem
- Auditors
- PwC Bedrijfsrevisoren BV/Reviseurs d’Entreprises SRL
Latest News for AGS
Upcoming Events for AGS
Ageas SA Annual Shareholders Meeting
Ageas SA Extraordinary Shareholders Meeting
Ageas SA Ordinary Shareholders Meeting
Dividend For AGES.BR - 2.0000 EUR
Half Year 2025 Ageas SA Earnings Release
FAQ
As of Today at 19:06 UTC, shares in Ageas SA are trading at €53.70. This share price information is delayed by 15 minutes.
Shares in Ageas SA last closed at €53.70 and the price had moved by +23.56% over the past 365 days. In terms of relative price strength the Ageas SA share price has outperformed the FTSE Global All Cap Index by +20.47% over the past year.
The overall consensus recommendation for Ageas SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ageas SA dividend yield is 4.56% based on the trailing twelve month period.
Last year, Ageas SA paid a total dividend of €2.45, and it currently has a trailing dividend yield of 4.56%.Looking ahead, shares in Ageas SA are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-06-06.
Ageas SA are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-06-06. The historic dividend yield on Ageas SA shares is currently 4.56%.
To buy shares in Ageas SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €53.70, shares in Ageas SA had a market capitalisation of €10.37bn.
Here are the trading details for Ageas SA:
- Country of listing: Belgium
- Exchange: BRU
- Ticker Symbol: AGS
Based on an overall assessment of its quality, value and momentum Ageas SA is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ageas SA is €54.60. That is 1.68% above the last closing price of €53.70.
Analysts covering Ageas SA currently have a consensus Earnings Per Share (EPS) forecast of €7.13 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ageas SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +11.04%.
As of the last closing price of €53.70, shares in Ageas SA were trading +10.73% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ageas SA PE ratio based on its reported earnings over the past 12 months is 7.33. The shares last closed at €53.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ageas SA's management team is headed by:
- Bart De Smet - CHM
- Hans De Cuyper - CEO
- Guy de Selliers de Moranville - NVC
- Christophe Boizard - CFO
- Emmanuel Van Grimbergen - CRO
- Antonio Cano - MDR
- Filip Coremans - MDR
- Veerle Verbessem - DIR
- Steven Braekeveldt - OTH
- Gary Crist - OTH
- Heidi Delobelle - OTH
- Andy Watson - OTH
- Valerie Van Zeveren - SEC
- Sonali Chandmal - NID
- Richard Jackson - NID
- Yvonne Lang Ketterer - NID
- Jane Murphy - NID
- Lionel Perl - NID
- Lucrezia Reichlin - NID
- Katleen Vandeweyer - NID
- Jan Zegering Hadders - NID